🇺🇸 FDA
Patent

US 7641909

Avirulent, immunogenic flavivirus chimeras

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 7641909 (Avirulent, immunogenic flavivirus chimeras) held by THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION
Grant date
Tue Jan 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/53, A61K2039/70